Pharmacists in Dansville, New York


13 Pharmacists found in Dansville
male pharmacist

Dr. Andrew Spencer, PHARM.D.


Pharmacist
9519 Foster Wheeler Rd, Dansville, NY 14437
585-335-6760    

female pharmacist

Christina Evans, PHARM.D


Pharmacist
9519 Foster Wheeler Rd, Dansville, NY 14437
585-335-6760    

male pharmacist

Christopher Mcaneney


Pharmacist
9519 Foster Wheeler Rd, Dansville, NY 14437
585-335-6760    



male pharmacist

Daniel J Carroll, RPH


Pharmacist
20 Village Plz, Dansville, NY 14437
585-335-8292     585-335-7137

male pharmacist

Everett M Hunt, RPH


Pharmacist
111 Clara Barton St, Dansville, NY 14437
585-335-4342     585-335-4314

male pharmacist

Frank Demarzo, RPH


Pharmacist
111 Clara Barton St, Dansville, NY 14437
585-335-4348     585-335-4314

male pharmacist

Mr. Jon Ferree, RPH


Pharmacist
9519 Foster Wheeler Rd, Dansville, NY 14437
585-335-6760     585-335-9137

female pharmacist

Katheryne Elizabeth Hassman, PHARMD


Pharmacist
62 Leonard St, Dansville, NY 14437
585-721-2957    

female pharmacist

Laura M Kreiley


Pharmacist
20 Village Plz, Dansville, NY 14437
585-335-8292    

female pharmacist

Megan Gee


Pharmacist
10036 Deer Park Dr, Dansville, NY 14437
585-703-2846    

male pharmacist

Scott D Wilson, RPH


Pharmacist
35 Franklin Plz, Dansville, NY 14437
585-335-2270    

female pharmacist

Dr. Tracy L Bauer, RPH


Pharmacist
9519 Foster Wheeler Rd, Dansville, NY 14437
585-335-6760     585-335-9137

female pharmacist

Zilin Wang


Pharmacist
60 Red Jacket St, Dansville, NY 14437
585-432-2398    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.